Wall Street Journal hails the nomination as potentially "one of Trump's most important appointments" (here). See a detailed analysis of Gottlieb's views on drug pricing is providing by the DrugChannels blog (here), with a callout to Gottlieb's insightful 10/2016 Hill testimony (here).
For MedCityNews, "Statistical Guide to Scott Gottlieb," March 15, 2017, here.
A interesting pre-election (9/2016) interview with Gottlieb is online, here.
A colorful article about the new administration, Peter Thiel, and FDA, at Vox, here. A negative article on Gottlieb at LA Times, here.